-
Aprepitant, sold
under the
brand name
Emend among others, is a
medication used to
prevent chemotherapy-induced
nausea and
vomiting and to
prevent postoperative...
- ****ociated with
cancer chemotherapy. An
example of a drug in this
class is
aprepitant. Chemotherapy-induced
emesis appears to
consist of
acute and dela**** phases...
-
antiemetic medication,
administered intravenously. It is a
prodrug of
aprepitant.
Fosaprepitant was
developed by
Merck & Co. and was
approved for medical...
-
receptor antagonists, can be used as
antiemetic agents, such as the drug
aprepitant. The
genes and
receptor ligands are as follows: (Hökfelt et al., 2001;...
-
vomiting (CINV). In general,
olanzapine appears to be
about as
effective as
aprepitant for the
prevention of CINV,
though some
concerns remain for its use in...
- termed: SP antagonists, or
tachykinin antagonists.) One such drug is
aprepitant to
prevent the
nausea and
vomiting that
accompanies chemotherapy, typically...
-
tomography (PET)
studies have
shown that
aprepitant can
penetrate the
brain and NK1
receptors in the brain.
Aprepitant has also been
shown to
increase the...
-
prevent an
emetic signal from
being transmitted.
Medications include aprepitant and rolapitant.
Histamine receptor antagonists can be
administered by...
-
discharged if they
still require IV therapy. Some medications, such as
aprepitant, are
chemically modified to be
better suited for IV administration, forming...
-
limited by
sedating properties)
Metoclopramide NK1
receptor antagonist Aprepitant (Emend) is a
commercially available NK1
receptor antagonist Casopitant...
